Objective: To analyze clinical outcomes after pelvic exenteration for advanced primary or recurrent pelvic cancer.
Material And Methods: We analyzed the outcomes in 35 patients after pelvic exenteration for advanced primary or recurrent pelvic cancer (gynecological cancer, urologic cancers, colon cancer). There were 3 (8.